BBMC

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies regarding how exposure over time may affect a pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the benefits of taking them against the potential risks to the foetus. The doctors don't have the information to make unambiguous recommendations but they can a general practitioner prescribe adhd medication provide information on risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not face an increased risk of fetal heart malformations or major structural birth defects. Researchers used a vast population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was correct and to reduce any bias.

However, the study was not without its flaws. Most important, they were unable to separate the effects of the medication from those of the disorder that is underlying. This makes it difficult for researchers to determine if the few associations observed between the groups exposed were due to the use of medications or if they were confounded by the presence of comorbidities. Additionally, the researchers did not look at long-term offspring outcomes.

The study found that babies whose mothers took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) as compared to mothers who did not take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications during early pregnancies can be offset by greater benefits for baby and mother of continued treatment for the woman's condition. Physicians should talk to their patients about this and try to help them develop coping skills that could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether to keep or stop treatment during pregnancy is one that doctors are having to face. Most of the time, these decisions are made without any evidence that is clear and definitive in either case, which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what the research says on the topic as well as their own best judgment for each individual patient.

The issue of potential risks for infants can be extremely difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are conflicting. Most studies limit their analysis to live births, which may underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion A few studies have revealed a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show that there is a neutral, or slightly negative, impact. In all cases it is imperative to conduct a thorough study of the risks and benefits must be performed.

For many women with ADHD, the decision to stop medication is difficult, if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. Furthermore, a loss of medication may affect the ability to do work-related tasks and safely drive, which are important aspects of daily life for many people suffering from ADHD.

She recommends women who are uncertain about whether or not to stop medication in light of their pregnancy, consider informing family members, friends and colleagues on the condition, its impact on daily life, and the advantages of staying on the current treatment regimen. It can also help women feel more confident in her decision. It is important to remember that certain medications can pass through the placenta therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug could be transferred to the child.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns over the impact that these drugs might have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The researchers behind the study found no association between early use of medication and congenital abnormalities like facial clefting, or most Popular adhd medication club foot. The results are in agreement with previous studies that have shown an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to the time of the birth of their child. The risk grew in the latter half of pregnancy, when a lot of women are forced to stop taking their ADHD medication.

Women who took ADHD medication during the first trimester were more likely require a caesarean delivery or have an insufficient Apgar after birth and had a baby that required breathing assistance when they were born. The authors of the study could not remove bias in selection since they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.

The researchers hope their research will help inform the clinical decisions of doctors who encounter pregnant women. The researchers suggest that, while discussing the risks and benefits are important, the decision about whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and her needs.

The authors also advise that while discontinuing the medications is an alternative, it is not an option to consider due to the high incidence of depression and other mental health problems among women who are pregnant or postpartum. Research has also shown that women who stop taking their medications will have a tough transitioning to life without them after the baby is born.

Nursing

The responsibilities of being a new adhd medication mother can be overwhelming. Women with ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments, Most Popular Adhd Medication prepare for the birth of a baby and adjust to new adhd medication uk routines. As such, many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant drugs pass through breast milk in low amounts, therefore the risk to breastfeeding infant is minimal. However, the rate of medication exposure to the infant can differ based on dosage, frequency it is taken and the time of the day the medication is administered. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not well known.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. It is a difficult decision for the woman who must weigh the benefits of her medication against the risks to the foetus. As long as more information is available, GPs may ask pregnant patients if they have any history of ADHD or if they are planning to take medication during the perinatal stage.

A growing number of studies have shown that Most popular Adhd medication women can safely continue to take their ADHD medication while they are pregnant and nursing. In response, an increasing number of patients are choosing to do so. They have discovered after consulting with their doctors, that the benefits of continuing their current medication far outweigh any risk.

Women who suffer from ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also be informed about treatment options and build strategies for coping. This should be a multidisciplinary effort with the GPs, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if needed modifications to the medication regime.